Smoking is a risk factor for many diseases and kills more than 8 million people globally every year. It is well established that any kind of smoking is harmful and seriously affects the cardiovascular and respiratory systems. COVID-19 can harm cardiovascular and respiratory systems while the damage caused to the lungs by smoking makes patients more susceptible to pulmonary infections, both bacterial and viral.
A systematic review of the most recent epidemiological data from the studies already published in China, concluded that smokers suffer more severely from COVID-19, being 2.4 times more likely to be admitted to an ICU, need mechanical ventilation or die compared to non-smokers (95% CI: 1.43–4.04); it seems that their probability of having severe symptoms is also increased (Δ: 40%).
In this new fact sheet, ENSP summarized evidence for smokers and novel tobacco users and made recommendations to be followed in the context of COVID-19 pandemic.
Read the full fact sheet (EN)…
Read the full fact sheet (FR)…
Read the full fact sheet (RO)…
Read the full fact sheet (AL)…
the Global Epidemic” As a part of the ENSP-ECTC Series of Webinars, the hot topic of novel tobacco products will be addressed during the session on Thursday, 3 December (13:00...
Together with the Campaign for Tobacco-Free Kids, ENSP will host another webinar on Tuesday, December 15, from 13:30 to 15:00 (CET), titled “Using Point of Sale Investigations to Successfully Advance TAPS...
ENSP is pleased to host the webinar “Tobacco Industry Tactics” that will be held on 2nd December 2020, from 13:00 to 14:30 CET, as part of the ENSP-ECTC Conference – The Online Edition. The...
